Trending 2018 : Treatment to Wellness

" [...] Abivax is developping ABX464 to reduce the HIV reservoir within infected partients and deliver long-lasting reductions in the viral load of patients." We hope to put HIV patients into remission or functional cure and eventually even a true cure by significantly reducing the viral reservoir of HIV, which could slow or even prevent HIV from rebounding for long periods after treatment," Dr. Ehrlich says. "Therapeutics delivering long-term wellness represent the greatest benefit to patients, and for this reason we believe that turning HIV from a viral therapy, to a curable desease would be a true value driver for patients and the socio-economic systeme at large".

To read more : PhamaVoice.Com

 

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41

More articles in French

Click here